Câncer invasivo do colo uterino
Palavras-chave:
Câncer, Colo uterino, TratamentoReferências
World Health Organization. Launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer. Disponível em: https://www.who.int/news-room/events/detail/2020/11/17/default-calendar/launch-of-the-global-strategy-to-accelerate-the-elimination-of-cervical-cancer.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil / Instituto Nacional de Câncer José Alencar Gomes da Silva. – Rio de Janeiro: INCA, 2019.
Harden ME, Munger K. Human papillomavirus molecular biology. Mutat Res Rev Mutat Res. 2017;772:3-12. doi: 10.1016/j. mrrev.2016.07.002. Epub 2016 Jul 5.
Primo WQSP, Primo GRP. Papilomavírus Humano. Aspectos Clínicos. FEMINA 2019;47(12): 850-66.
Perkins RB, Guido RS, Castle PE et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower GenitalTractDisease•Volume24, Number 2, April 2020.
Apgar SB, Brotzman GL, Spitzer M. Colposcopy: Principles and Practice. An Integrated Textbook and Atlas. Philadelphia: Saunders; 2002. p. 560.
OMS. Classificação histológica dos tumores do colo do útero. Disponível em: screening.iarc.fr. Acessado em: 5 de maio de 2021.
Disaia PPJ, Creasman WTT. Clinical gynecology. 9ª ed. Missouri: Mosby; 2018. p. 38-104.
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. FIGO CANCER REPORT 2018. Int J Gynecol Obstet 2018; 143 (Suppl. 2): 22–36.
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri”. Int J Gynecol Obstet 2019; 147: 279–280.